Literature DB >> 1647646

Effect of vitamin E succinate and a cAMP-stimulating agent on the expression of c-myc and N-myc and H-ras in murine neuroblastoma cells.

R J Cohrs1, S Torelli, K N Prasad, J Edwards-Prasad, O K Sharma.   

Abstract

D-Alpha-tocopheryl succinate (vitamin E succinate) at a concentration of 11.3 microM inhibited growth and reduced the expression of c-myc, N-myc and H-ras specific mRNAs in murine neuroblastoma cells (NBP2) in culture. R020-1724 [4-(3-butoxy-4-methoxybenzyl)-2- imidazolidinone], an inhibitor of cyclic AMP phosphodiesterase, also inhibited growth and reduced the expression of these oncogenes. Vitamin E succinate treatment caused the formation of two c-myc related transcript of 1.9 and 3.7 kb; however, R020-1724 treatment did not. These results suggest that the inhibition of growth is sufficient to reduce the expression of c-myc, N-myc and H-ras in NB cells in culture, but it is not sufficient to produce two c-myc related transcripts.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1647646     DOI: 10.1016/0736-5748(91)90011-a

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  5 in total

1.  In vitro and in vivo inhibition of SK-N-MC neuroblastoma growth using cyclic nucleotide phosphodiesterase inhibitors.

Authors:  M Giorgi; C Leonetti; G Citro; G Augusti-Tocco
Journal:  J Neurooncol       Date:  2001-01       Impact factor: 4.130

2.  Cyclic AMP inhibits c-Ha-ras protooncogene expression and DNA synthesis in rat aortic smooth muscle cells.

Authors:  D N Sadhu; K S Ramos
Journal:  Experientia       Date:  1993-07-05

3.  Posttranscriptional down-regulation of ras oncogene expression by inhibitors of cellular glutathione.

Authors:  A C Miller; J Gafner; E P Clark; D Samid
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

4.  Altered expression of genes regulating cell growth, proliferation, and apoptosis during adenosine 3',5'-cyclic monophosphate-induced differentiation of neuroblastoma cells in culture.

Authors:  Xiang-Dong Yan; Amy J Hanson; Piruz Nahreini; William T Koustas; Cynthia Andreatta; Kedar N Prasad
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-10       Impact factor: 2.723

5.  Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma Models.

Authors:  Ivan S Alferiev; David T Guerrero; Danielle Soberman; Peng Guan; Ferro Nguyen; Venkatadri Kolla; Ilia Fishbein; Blake B Pressly; Garrett M Brodeur; Michael Chorny
Journal:  Int J Mol Sci       Date:  2022-02-03       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.